Follow The Filings

SUPN Supernus Pharmaceuticals Inc.

Health Care, filed as Supernus Pharmaceuticals, Inc. (COM), Equity As of 2026 Q3 so far: 135 of 140 managers we track have filed Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q3

  • 2 Owners
  • Max 5.7%
  • $22M
  • 1 add 1 small

In 2026 Q3 Michael Krensavage added to Supernus Pharmaceuticals.

Who owns this now

Largest portfolio weights among holders, up to 5.7% (Michael Krensavage, Krensavage Asset Management). Not free-float ownership.

  1. Michael Krensavage Add 5.7%
  2. Third Avenue Management Add 1.1%

Who owns SUPN

Sorted by value, long equity only, as of 2026 Q3.

History
Michael Krensavage, Krensavage Asset Management 5.7%, was 5.0% Add +24.9% 350,681 $15M History
Third Avenue Management 1.1% Small add +2.9% 157,150 $6.8M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by SUPN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SUPN insider trades
  • None no insider bought on the open market
  • $1.8M sold by 4 insiders outside a trading plan
  • $8.4M sold by 4 insiders under 10b5-1 plans
  1. Padmanabh P. Bhatt Sr. VP of IP, CSO
    Planned sale
    $5.4M 107,250 shares at $50.24 86% of stake
    Traded Mar 16–18 Filed Mar 18
  2. Jack A. Khattar CEO
    Planned sale
    $1.8M 35,000 shares at $50.37 3.5% of stake
    Traded Mar 13 Filed Mar 16
  3. Frederick M. Hudson Director
    Sale
    $272K 5,369 shares at $50.61 8.2% of stake
    Traded Mar 12 Filed Mar 16
  4. William Todd Horich SVP, Commercial Operations
    Sale
    $484K 8,877 shares at $54.50 100% of stake
    Traded Mar 9–10 Filed Mar 10
  5. Frank Mottola SVP, Chief Tech. Ops. Officer
    Sale
    $87K 1,623 shares at $53.65 8.1% of stake
    Traded Mar 9 Filed Mar 10
  6. Georges Gemayel Director
    Sale
    $1M 18,787 shares at $53.38 41% of stake
    Traded Mar 5–6 Filed Mar 9
  7. Bethany Sensenig Director
    Planned sale
    $228K 4,475 shares at $51.01 100% of stake
    Traded Feb 19 Filed Feb 23
  8. Frank Mottola SVP, Chief Tech. Ops. Officer
    Planned sale
    $1M 20,000 shares at $50.41 56% of stake
    Traded Dec 19, 2025 Filed Dec 22, 2025
  9. Jack A. Khattar CEO
    Planned sale
    $3M 59,900 shares at $50.57 4.7% of stake
    Traded Oct 9, 2025 Filed Oct 10, 2025
  10. Charles W. Newhall III Director
    Planned sale
    $1.3M 25,000 shares at $50.77 19% of stake
    Traded Oct 9, 2025 Filed Oct 10, 2025

Also filed in the last 12 months, not counted as buying or selling: 28 share withholdings for taxes, 27 option exercises, 20 stock grants, 12 other transactions, and 1 sale to cover taxes.

Congress

1 member of Congress traded SUPN in the last three years: 3 buys and 1 sale. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Mar 3 filed Apr 7
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Dec 11, 2025 filed Jan 12
  3. Gilbert Ray Cisneros, Jr. D-CA-31 Partial sale $1K–$15K Oct 9, 2025 filed Nov 18, 2025
  4. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Mar 24, 2025 filed Apr 7, 2025

SEC filings

Recent issuer filings from EDGAR, 18 shown.

Filed Form Detail Links
8-K 3.01
8-K 1.01,2.01,2.03,3.03,5.01,5.03,7.01,9.01
10-Q
8-K 2.02,9.01
8-K 1.02,9.01
8-K 8.01,9.01
8-K 2.02
8-K 5.07,9.01
DEFA14A
SCHEDULE 13G/A —
8-K 1.01,5.02,8.01,9.01
DEFA14A
8-K 2.02,9.01
10-Q
8-K 8.01,9.01
DEFA14A
8-K 8.01,9.01
DEFA14A

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2024 FY2025
Revenue $1.19B $1.24B
Gross profit $957M $994M
Gross margin * 80.6% 80.2%
Net income $2M $210M
Net margin * 0.2% 16.9%

Balance sheet

Metric FY2024 FY2025
Total current assets $839M $652M
Total non-current assets * $480M $549M
Total assets $1.32B $1.2B
Total current liabilities $939M $914M
Total non-current liabilities * $729M $386M
Total equity -$348M -$98M

Cash flow

Metric FY2024 FY2025
Cash from operations $36M -$27M
Cash from investing $69M -$66M
Cash from financing -$102M -$30M
Net change in cash * $3M -$123M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf